Page last updated: 2024-09-03

12-(1-pyrene)dodecanoic acid and Addison Disease and Cerebral Sclerosis

12-(1-pyrene)dodecanoic acid has been researched along with Addison Disease and Cerebral Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imanaka, T; Kawaguchi, K; Matsumoto, S; Matsuya, Y; Minato, D; Morita, M; Okazaki, A; Shimozawa, N; Tomita, K; Watanabe, S1

Other Studies

1 other study(ies) available for 12-(1-pyrene)dodecanoic acid and Addison Disease and Cerebral Sclerosis

ArticleYear
A novel method for determining peroxisomal fatty acid β-oxidation.
    Journal of inherited metabolic disease, 2016, Volume: 39, Issue:5

    Topics: Adrenoleukodystrophy; Carnitine Acyltransferases; Cells, Cultured; Fatty Acids; Fibroblasts; Humans; Lauric Acids; Lipid Metabolism, Inborn Errors; Mitochondria; Oxidation-Reduction; Peroxisomal Disorders; Peroxisomes; Pyrenes; Skin; Zellweger Syndrome

2016